Skip to Main Content

Yale Center for Immuno-Oncology Symposium on Friday, Oct. 11

October 01, 2019

The Yale Center for Immuno-Oncology builds on Yale Cancer Center and Smilow Cancer Hospital’s international leadership in immunobiology, cancer immunology, and the development of novel cancer immunotherapies to effectively broaden our translational research infrastructure. 

Please join us for a day-long symposium highlighting advancements in immuno-oncology and featuring leaders in immunology from around the country for presentations, discussion, and networking.


Yale Center for Immuno-Oncology Symposium Agenda

Friday, October 11, 2019

Harkness Auditorium

08:30 - 09:00                Registration and Breakfast

09:00 - 09:15                Opening remarks

                                    Charles S. Fuchs, MD, MPH, Director, Yale Cancer Center; Physician-in-Chief, Smilow Cancer Hospital

                                    David Schatz, PhD, Chair, Department of Immunobiology

                                    Roy S. Herbst, MD, PhD, Chief of Medical Oncology; Associate Director for Translational Research; Ensign Professor of Medicine

                                    Marcus Bosenberg, MD, PhD, Professor of Dermatology, Pathology, and Immunobiology, Co-Leader, Genetics, Genomics and Epigenetics Research Program; Interim Director, Yale Cancer for Immuno-Oncology

                                   

                                    Visualizing tumor immunity and response

09:15 – 10:15               Anna Wu, PhD, Professor and Chair, Department of Molecular Imaging and Therapy, Beckman Research Institute, City of Hope

10:15 – 10:45               David Rimm, MD, PhD, Professor of Pathology and of Medicine, Yale School of Medicine

10:45 – 11:00               Coffee break

                                    Taming the tumor microenvironment ecosystem

11:00 – 12:00               Greg M. Delgoffe, PhD, Assistant Professor, Immunology, University of Pittsburgh

12:00 – 1:00                Drew Mark Pardoll, MD, PhD, Director, Bloomberg-Kimmel Institute for Cancer Immunotherapy, Abeloff Professor of Oncology, Johns Hopkins University

1:00 – 2:00                   Lunch

                                    Improving therapeutic success  

2:00-3:00                     Cornelia Liu Trimble, MD, Professor of Gynecology and Obstetrics, Oncology and Pathology, Johns Hopkins School of Medicine

3:00-3:30                     Katerina Politi, PhD, Associate Professor of Pathology, Yale Cancer Center

3:30-3:45                    Coffee break

                                    Developing Novel and Cell-Based Therapies

3:45-4:15                     Lieping Chen, MD, PhD, United Technologies Corporation Professor in Cancer Research and Professor of Immunobiology, Dermatology and Medicine (Medical Oncology), Yale School of Medicine

4:15-4:45                     Mario Sznol, MD, Professor of Medicine (Medical Oncology), Yale Cancer Center

4:45-4:50                     Closing remarks

                                    Roy S. Herbst, MD, PhD, Chief of Medical Oncology; Associate Director for Translational Research; Ensign Professor of Medicine

                                   Marcus Bosenberg, MD, PhD, Professor of Dermatology, Pathology, and Immunobiology, Co-Leader, Genetics, Genomics and Epigenetics Research Program; Interim Director, Yale Cancer for Immuno-Oncology

Submitted by Robert Forman on October 01, 2019